Scientists have developed improved methods for generating micro-organospheres (MOS) and have shown that they can be used as patient avatars for studies involving direct viral infection, immune cell penetration and high-throughput therapeutic drug screening - something that is not obtainable with conventional patient-derived models. (IMAGE)

Terasaki Institute for Biomedical Innovation

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.